3 generic drugmakers accused of ‘stonewalling’ congressional probe

(By Alia Paavola for Becker’s Hospital Review)

Two lawmakers have accused three generic drugmakers of “coordinated obstruction” and “apparent efforts to stonewall” a 2014 probe into their pricing strategies, according to CNBC.   Continue reading article here…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.